Skip to content

Long Term Outcome Study in Patients With Pituitary Disorders

Long Term Outcome Study in Patients With Pituitary Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03665064
Enrollment
1500
Registered
2018-09-11
Start date
2000-01-01
Completion date
2026-12-31
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pituitary Diseases, Pituitary Neoplasms

Keywords

Pituitary tumor, Acromegaly, Cushing, Prolactinoma

Brief summary

To determine the outcomes of patients with different pituitary disorders whether they are managed medically, surgically or expectantly.

Detailed description

A chart audit of around 1500 patients seen in two specific clinics, the Medical Pituitary Clinic and the combined Endocrine/Neurosurgical Pituitary Clinic at the University of Alberta Hospital, will be performed to determine the effectiveness of various treatment strategies on the long term outcome of specific pituitary disorders. The investigator's will collect retrospective demographic (age, sex, ethnicity), clinical (mode of presentation, hormonal parameters) and therapeutic outcome (surgical, medical, expectant and / or radiation treatment; co-morbidities and complications) of patients seen in these two clinics between January 2000 and December 2020.

Interventions

None listed

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients with confirmed pituitary disease

Exclusion criteria

* patients who do not have confirmed pituitary disease

Design outcomes

Primary

MeasureTime frameDescription
Progression free survival after pituitary surgeryup to 17 years post surgeryUsing clinical, biochemical and imaging studies of a cohort of surgically operated patients to identify prognostic factors of tumor recurrence

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026